What do patients and caregivers really think about naloxone?
NCT ID NCT04129138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveys 182 high-risk patients and their caregivers to understand their attitudes and beliefs about being prescribed intranasal naloxone spray, a medication that reverses opioid overdoses. The goal is to find out what barriers exist to prescribing this life-saving spray and how to better educate patients and families. Participants include patients who have already been prescribed naloxone in the past year and their caregivers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAREGIVER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Teamwork in care: could shared Self-Care lessons ease the toll of breast cancer treatment?
- A simple lesson before discharge could ease the heavy load on family caregivers
- Pre-Surgery video may calm nerves and boost understanding in colorectal cancer patients
- Caregiver burnout breakthrough? study tests Home-Based wellness program
- Video training for PEG tube caregivers may cut stress and boost skills
- Can a smartphone app ease the burden on home palliative caregivers?